title: The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
abstract: The TP63 gene, a member of the TP53 gene family, encodes several isoforms with (TAp63) or without (DeltaNp63) transactivating properties. Whereas the role of p63 in the normal development of squamous epithelia is well established, its function in other cell types remains to be elucidated. Here, we have analysed the expression of TA and DeltaNp63 isoforms in liver cells, by using both primary hepatocytes from wild type and p53-null mice and three human hepatocellular carcinoma (HCC) cell lines, according to the transformation state and the TP53 status of the cells. We observed the expression of DeltaNp63 isoforms only in a p53-null context. On the other hand, the expression of TAp63 isoforms was restricted to the HCC cell lines, whatever the TP53 status. We then studied the expression of TP63 upon genotoxic treatment. When treated with UVB or H(2)O(2), hepatocytes did not exhibit any change in p63 mRNA level. At the opposite, upon treatment with topoisomerase II inhibitors (doxorubicin or etoposide), the expression of TAp63 isoforms was clearly induced, independently of the TP53 status of cells. The same treatment did not induce any variation in the expression of DeltaNp63 isoforms, both at mRNA and protein levels. In HCC cell lines, doxorubicin or etoposide treatment also resulted in an increase of TAp63 transcripts only. This increase was accompanied by an increase in the intracellular level of TAp63 alpha protein. In parallel, we observed an upregulation of some p53-target genes related to cell cycle regulation, such as WAF1/CIP1, PIG3, 14-3-3sigma or GADD45, independently of the TP53 status of cells. In conclusion, we report for the first time that TA and DeltaNp63 alpha proteins are present in liver cells. Furthermore, our results suggest that p63 may partially substitute for wild-type p53, in counteracting uncontrolled liver cell proliferation in response to certain forms of DNA-damage.
authors.affiliation: International Agency for Research on Cancer, 150 cours A Thomas, 69372 Lyon Cedex 08, France.
authors.forename: Audrey
authors.initials: A
authors.lastname: Petitjean
authors.forename: Catherine
authors.initials: C
authors.lastname: Cavard
authors.forename: Hong
authors.initials: H
authors.lastname: Shi
authors.forename: Violaine
authors.initials: V
authors.lastname: Tribollet
authors.forename: Pierre
authors.initials: P
authors.lastname: Hainaut
authors.forename: Claude
authors.initials: C
authors.lastname: Caron de Fromentel
mesh_terms: D016475:3T3 Cells; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000235:genetics; D045744:Cell Line, Tumor; D016158:Genes, p53; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics; D051379:Mice; D005810:Multigene Family; D010750:Phosphoproteins / Q000235:genetics*; D020033:Protein Isoforms; D012333:RNA, Messenger / Q000235:genetics; D015534:Trans-Activators / Q000235:genetics*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D010750:Phosphoproteins; D020033:Protein Isoforms; D012333:RNA, Messenger; D015534:Trans-Activators; C486419:Trp63 protein, mouse; D016159:Tumor Suppressor Protein p53